Baku 8° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
19:03
Winter season begins in Azerbaijan
Domestic policy17:53
Yilmaz: South Caucasus becoming new geopolitical hub focused on cooperation
Region17:41
Yilmaz: Acceleration of peace process between Azerbaijan, Armenia - important stage
Infrastructure17:23
Ohio State researchers find increasing type of protein helps slow down heart failure
Health17:00
UK chancellor of exchequer banned from her favorite pub due to tax increases
Other countries16:41
Georgian Foreign Ministry outlines priorities of country's BSEC chairmanship
Region16:15
Azerbaijan, Türkiye to hold meeting of intergovernmental commission in Baku
Business15:43
Thailand doesn't rule out possibility of ceasefire in conflict zone with Cambodia
Other countries15:22